Key result
Decellularized aortic valve homografts for aortic valve replacement in 69 patients resulted in no graft dilatation and excellent hemodynamics over a mean follow-up of 2.0 years.
Authors
Loading...
Supports decellularized homografts for aortic replacement; leaves open durability and randomized comparisons beyond 2 years.
Observational (n=69)
Tudorache et al. (2016) conducted an observational in Aortic valve disease (n=69). Decellularized aortic valve homografts (DAHs) was evaluated. Decellularized aortic valve homografts for aortic valve replacement in 69 patients resulted in no graft dilatation and excellent hemodynamics over a mean follow-up of 2.0 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: